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For serial cultivation of normal human melanocytes media 
supplemented with the tumor promoter 12-0-tetradecan-
oylphor bol-13-acetate (TPA) ~re larg.ely ~mployed . By using 
culture medium that permits cultlvatlOn of melanocytes ~ithout TPA, the effects of TPA on melanocyte prolifera-
tion phenotype, and susceptibility to lymphokine-activated 
kill;r cells were stud.ied. Ad~ition of 5? ngJm! TPA to the 
medium induced rapid dendnte for~atlo~ and mC.reased t~e 
cell proliferation rate by 16 - 63% In mltogen-nch media 
(four of seven cultures, p < 0.01), and by 237% in mitogen-
educed media (p < 0.001). Furthermore, several pheno-~piC changes indicating early stages of melanocyte transfor-
mation were induced by 50 ngjml TPA. These included 
. ncreased expression of melanoma progression - associated 
I ntigens such as A.1.43 and A.1 0.33, upregulation of nerve-~rowth factor receptor as well as of the melanocyte-activa-
tion marker HMB-45 and of histocompatibility class I anti-
N ormal human melanocytes require, in contrast to malignant melanoma cells, the presence of several mitogens to establish cell growth in lIilro [1-3J. For this purpose, the tumor-promoting phorbol ester 12-0-tetradecanoylphorbol-13-acetate (TPA) is a 
widely used compound. TPA acts on the cell presumably through 
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Abbrevia tions: 
CMM: complete melanocyte medium 
DMSO: dimethylsulfoxide 
FAC5: fluorescence-activated cell sorter 
4-MUH: 4-methylumbelliferyl heptanoate 
HLA(-I)(-DR): histocompatibility antigen (class I) (-DR) 
ICAM -1: intercellular adhesion molecule-l 
LA!< cells: Iymphokine-activated killer cells 
NGF: nerve-growth factor 
NK: natural killer 
PBS: phosphate-buffered saline 
RMM: reduced melanocyte medium 
TP A: 12-0-tetradecanoylphorbol-13-acetate 
gens. In contrast, the expression of the differentiation marker 
K.1.2 and of intercellular adhesion molecule-1 was decreased 
in TP A-treated cultures. Most of these changes persisted even 
after removal ofTPA from the culture medium (~2 weeks). 
Staurosporine, a protein kinase C inhibitor, modulated mela-
nocyte-antigen expression similar to TPA, suggesting that 
protein kinase C downmodulation rather than activation by 
TPA is involved. In addition to the antigenic alterations, the 
susceptibility of TP A-treated melanocytes to Iympho-
kine-activated killer cell cytotoxicity decreased by 40% 
(p' < 0.01), possibly due to their altered surface antigen ex-
pression. The presented data reveal that the tumor promoter 
TPA hitherto used as a supplement of melanocyte culture 
media induces profound phenotypic and functional changes 
of the cultured cells, indicating incipient transformation of 
normal human melanocytes ill lIitro. ] Jnllest Dermatol 
100:653-659, 1993 
binding to protein kinase C (4], a key enzyme in signal transduction, 
and the transcription factor complex AP1 [5] . TPA is able to induce 
a plethora of cellular responses, including the induction of epider-
mal hyperplasia in mouse epidermis [6], enhancement of transfor-
mation efficiency of initiated cells [7,8], and even changes in the 
differentiation state of the cell [9,1OJ. . 
Studies in cell culture revealed two major features ofTPA. First, it 
induces at nanomolar concentrations several changes that resemble 
those seen in cells transformed by chemical carcinogens or tumor 
viruses and, second, it can affect cell differentiation [11,12J. TPA 
exerts apparently opposing effects on normal and transformed mela-
nocytes. It has been shown to inhibit growth and to induce differen-
tiation of melanoma cells ill vitro [13 - 15J. By contrast, the prolifera-
tion of normal melanocytes is enhanced upon treatment with TPA 
[1,3,16], and markers of cell differentiation are affected, such as 
decrease of melanin synthesis [1], upregulation of nerve-growth 
factor (NGF) receptor expression (17] and induction of his toe om pat-
ibility (HLA)-DR on some of the cultured melanocytes [18] . 
Detailed investigations on the nature of the effects of TPA on 
normal human melanocytes were in part hindered because TPA 
itself was a prerequisite for expanding cultured cells. Recent ad-
vances in culture technology, however, allowed serial cultivation of 
melanocytes in the absence of TPA [2J. In the present study, to 
better understand the biologic effects of TP A and its potential 
tumor-promoting activity on normal human melanocytes, we 
added TPA to melanocytes cultured in TPA-free media and exam-
ined the proliferation rate, expression of melanoma antigens asso-
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ciated with differentiation and tumor progression including HLA 
and intercellular adhesion molecule-l (ICAM-l) antigens. Further-
more, the susceptibility of normal human melanocytes in vitro to 
natural killer (NK) cells and interleukin-2-activated lymphocyte 
(LAK cell) cytotoxicity has been studied in both unsupplemented 
and TPA-supplemented cultures. 
MATERIALS AND METHODS 
Melanocyte Culture Epidermal cell suspensions, obtained from 
foreskins of children by overnight digestion in trypsin (0.25% in 
phosphate-buffered saline [PBS] without Ca++ and Mg++) at 4°C, 
were transferred to complete melanocyte medium (CMM) [19]. 
CMM consisted of MCDB 153 (Biochrom, Berlin, Germany) sup-
plemented with aminoacids [20] (Sigma, St. Louis, MO), 2 mM 
Ca++, 5 J.lg/ml insulin (Sigma), 10 J.lg/ml human transferrin 
(Sigma), 0.4% v /v whole bovine pituitary extract (Clonetics Inc., 
San Diego, CAl, 2 ng/ml bovine basic fibroblast growth factor 
(Boehringer Mannheim, Germany), 1 nM cholera toxin (Calbio-
chem), 50 J.lM hydrocortison (Serva, Heidelberg, Germany), and 
antibiotics. Two percent fetal calf serum (Biochrom) was added for 
the first 3 d of primary culture (in combination with 100 J.lg/ml 
geneticin (Gibco, BRL, Paisley Scotti and), and fetal calf serum for 
the first 24 h of each subculture. Keratinocytes grew poorly in this 
medium and died after 15 - 20 d. Pure primary melanocyte cultures 
were obtained, as could be shown by staining with S-1 00 antibodies 
using the alkaline phosphatase - antialkaline phosphatase method. 
To demonstrate the effect of TPA on melanocyte proliferation 
under sub-optimal mitogenic conditions, a mitogen-reduced var-
iant of CMM with omitted pituitary extract and basic fibroblast 
growth factor designated as reduced melanocyte medium (RMM) 
was used. For the experiments described below, first- or second-pas-
sage melanocyte cultures obtained from nine different donors (nor-
mal hum<).n melanocytes, NHM 2-10) were used. 
Proliferation Assays First-passage normal human melanocytes 
were seeded in tissue culture plates (96 flat-bottomed wells) (Becton 
Dickinson, Heidelberg, Germany) at 2 X 103 cells/well in 0.2 ml 
of CMM supplemented with 2% fetal calf serum. One day later, the 
cultures were washed two times with CMM or RMM and further 
incubated with fresh CMM or RMM, respectively, containing 10-
200 ng/ml TPA (Sigma) dissolved in dimethylsulfoxide (DMSO) 
or solvent (0.001 - 0.02% DMSO) (Merck, Darmstadt, Germany) 
alone. Stock solutions ofTPA or staurosporine in DMSO (1 mg/ 
ml) were kept light protected at - 20° C. Fresh medium containing 
various concentrations ofTPA or vehicle (D MSO) was given on day 
4. Cell proliferation has been determined on day 7 by a previously 
described fluorometric microassay [19,21,22]. This method is based 
on the hydrolysis of the nonfluorescent substrate 4-methylumbelli-
feryl heptanoate (4-MUH) (Sigma) to the fluorescent substance 
4-methylumbelliferon by intracellular esterases of living cells. The 
fluorescence values measured by a Titertec Fluoroscan II (Flow 
Lab., Meckenheim, Germany) correlated well with cell counts per-
formed independently. 
Monoclonal Antibodies The modulation of the antigen expres-
sion of normal human melanocytes by TPA in vitro was studied in 
CMM using the following monoclonal antibodies: HMB-45 (Enzo, 
NY) as a pigment cell-specific marker detecting activated melano-
cytes, K.1.2 (Zelldiagnostika Gmbh, Munster, Germany) staining a 
melanoma antigen negatively associated with !TIalignancy, A.I0.33 
and A.l.43 (Zelldiagnostika Gmbh) as melanoma progression 
markers, B 9.12.1 (Immunotech SA, Marseille, France) against 
HLA class I antigens, L243 (Becton Dickinson, Mountain View, 
CAl detecting HLA-DR class II antigens, 84H 1 0 (Immunotech SA) 
reacting with the lCAM-l molecule, 193 (Oncogene Sci, USA) 
against the NGF-receptor and BL6 for CD1 antigen. All monoclo-
nal antibodies have been described elsewhere [23 - 30]. 
Immunocytochemistry and FACS Analysis The immunocy-
tochemistry was performed using the alkaline phosphatase-
antialkaline phosphatase method, on acetone-fixed, air-dried cyto-
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spin preparations of ethylcndiamine tetraacetic acid-treated (0.5% 
in PBS) melanocyte cultures as previously described [31]. After in-
cubation with the primary mouse monoclonal antibody, a rabbir 
antimouse immunoglobulin G (Dakopatts, Glostrup, Denmark) 
and an antibody conjugated with alkaline phosphatase (Dianova, 
Hamburg, Germany) were applied. The slides were counterstained 
with Meyer'S hematoxylin (1 %). Negative controls were obtained 
by omitting the primary antibody. For fluorescence-activated cell 
sorter (FACS) analysis, samples of 5 X 105 viable ethylendiamine 
tetraacetic acid - treated melanocytes (0 .5% in PBS), were incubated 
with 100 J.l1 dilutions of various monoclonal antibodies for 30 min 
on ice. Samples were then washed twice in cold PBS and incubated 
for another 30 min on ice with a goat anti mouse immunoglobulin 
conjugated with fluorescein isothiocyanate (Dakopatts). After three 
washes with PBS cells were fixed in cold para formaldehyde (1 % in 
PBS) and analyzed with a flow cytometer (Epics 752, Coulter Elec-
tronics). Non-specific staining was determined by omitting the pri-
mary antibody. 
Natural Killer (NK) Cells, Generation ofLAK-Cell Activity, 
and Cytotoxicity Assays Peripheral blood lymphocytes from 
heparinized blood of healthy volunteers were separated on Ficoll-
hypaque (Pharmacia LKB, Sweden). The lymphocytes were then 
washed three times in RPMI 1640 plus 10% heat-inactivated fetal 
calf serum and antibiotics. Lymphocytes were adhered to culture 
dishes for 1 h to remove monocytes/macrophages and either used 
immediately as NK cells or seeded at 106/ ml in culture flasks. Lym-
phocytes were cultured for a further 4 d in the presence of recombi-
nant interleukin-2 (1000 Cetus units/ml) to generate lymphokine 
activated killer cells (LAK cells). Four-hour cytotoxicity assays have 
been performed using the f1uorometric MUH assay. Briefly, first-
passage melanocyte cultures obtained in CMM were grown in tissue 
culture cluster plates and treated over 6 d with 0 or 50 ng/ml TPA. 
On day 7, cultures were washed three times with RPMI 1640 plus 
0.1 % bovine serum albumin (Boehringer Mannheim) and incu-
bated with 200 jil NK- or LAK-cell suspension/well in RPM! 
1640 + 0.1 % bovine serum albumin at various effector to target 
(E/T) ratios. To adjust appropriate E/T ratios, cell numbers were 
determined in both TPA-treated and non-treated melanocyte cul-
tures of six different wells, respectively. After the 4-h cytotoxici ty 
assay, medium containing the effector cells was removed by flicking 
the plate. Cultures were then washed with PBS containing a low 
concentration of ethylendiamine tetraacetic acid (0.01 %) followed 
by two washes with PBS only, to ensure an almost complete re-
moval of lymphocytes and culture plates were proceeded for the 
MUH assay. Control cultures (c) that received no effectors were 
treated identically. Another series of control wells (el) was per-
formed using wells that received respective numbers of effectors bur 
no targets. The percent cytotoxicity was expressed as 
(C - D) - (E - Cl) percent cytotoxicity = 100 X C ' 
where C represents the fluorescence values of the control cultures c, 
Cl the fluorescence of the effectors remaining in control wells c1 
after 3 washes, D the fluorescence of the detached targets in the c 
cultures without effectors after three washes, and E the fluorescence 
values of the samples that received LAK cells. Background fluores-
cence due to non-specific adherence of effector cells (Cl), as well as 
due to target-cell detachment during washing (D) were less than 5% 
of C. Cytotoxicity rates obtained with the MUH assay correlate 
well with those of the StCr-release assay [32]. 
Statistics Proliferation experiments and cytotoxicity assays were 
performed five times; mean values and standard deviations were 
calculated. Statistical differences were evaluated by the two-sided 
Student t test. 
RESULTS 
Effect ofTPA on Melanocyte Proliferation The influence of 
TP A on melanocyte growth was studied both in CMM and in 
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. e 1. Effect of TPA (10-200 ngjml) on proliferation of normal ~~gu;n m elanocytes in CMM. 2 X 103 cells were incubated for 6 d with C~ containing TPA or DMSO. On day 7 cell proliferation was assessed 
'th the MUH fluorometric assay. Mean values and standard deviations 
; = 5) were calculated. AFU, absolute fluorescence units. 
RMM. In C MM, TPA exerted a dose-depe~ldent stimulatory effect 
elanocyte proliferatIO n after 6 d of ll1cubatlon, as could be o~ m n using the MUH-fluorometric assay (Fig 1). Maximal cell 
s o~feration occurred at a TPA dose of 50 ngjml. The growth-sti-
prol
l 
tory action ofTPA in CMM was generally moderate and signif-~u :ly increased proliferation rates were found in four of seven rff rent melanocyte cultures examined (17 -63%, p < 0.01) (Fig 2) ;'he effect of TPA on cell proliferation was more profound, h n the compound was added on melanocyte cu ltures maintained ~ . Figure 3 shows that addition ofTPAatadoseof50ng/ml 
In lted in 237% stimulation of proliferation on slowly growing ~~M.-I0 c ultures maintained i~l RMM (p < 0.001) . In contras t, no 
. ni11cant increase 111 the proliferation rates by TPA was seen 111 
rgt_growing NHM-I0 cultures maintained in CMM. In all TPA-
:eated cultures melanocytes exhibited a neuron-like dendritic mor-
phology. 
Modulation of Melanocyte Antigen Expression by TP A 
The phenotypic charactens tzcs of TP A-treated melanocytes, as de-
mined by monoclonal antibodies, have been examined in first- or :~ond-passage melanocyte cultures after 6 d incubation in CMM 
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Figure 2_ Effect of 50 ng/ml TrA on pmliferation of normal human 
melanocytes of seven clifferent cultures mamtamed m CMM. 2 X 103 cells 
were incubated for 6 d with CMM containing TrA or DMSO. On day 7 
cell proliferation was ass~s~ed with the MUH fluorometric assay. Mean 
values and standard devIatIOns (n = 5) were calculated . AFU, absolute 
fluorescen ce units. 
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Figure 3. Comparison of the effect of TP A on the proliferation of NHM-
10 melanocytes maintained either in CMM or in RMM; 2 X 103 cells were 
incubated for 6 d with CMM or RMM both containing either TPA or 
DMSO. On day 7 cell proliferation was assessed with the MUH fluorome-
tric assay. Mean values and standard deviations (n = 5) were calculated. 
AFU, absolute fluorescence units. 
containing 50 ng/ml TPA in DMSO, in comparison to cultures 
maintained in CMM with DMSO only (0.005%). TPA-free cul-
tured melanocytes expressed significant amounts of HMB-45 on 
their surface (25 -85% positive cells) (Fig 4), although to a much 
lower degree than melanoma cel ls (data not shown). Six days expo-
sure of melanocytes to TPA greatly induced expression ofHMB-45 
on cell surface in all cell cultures studied (60 - 100% positive cell s) 
(Figs 4 and 5), and also the expression of NGF receptor was found 
consistently upregulated after TPA-exposure in all cultures (con-
trols, 19-61% positive cells; TPA treated, 38-82%). The expres-
sion of A.l.43 and A.I 0.33 , both ill situ markers of melanoma pro-
gression, was upregulated by TPA in five of eight and in four of 
eight cultures, respectively (Fig 4). Treatment of the cultures for a 
longer period of20 d did not further stimulate expression of A.l.43 
and A.t 0.33. Staining with K.1.2 was found reduced after TPA in 
four of five melanocyte cu ltures examined (Fig 6). Figl're 4 shows 
that ICAM-1 molecule was variably expressed in TPA-free control 
melanocyte cultures (43 - 75% positive ce lls). In five of nine melano-
cyte cultures a substantial reduction in the number of ICAM-1 + 
melanocytes was induced by TPA. All melanocyte cultures ex-
pressed HLA class I molecules on 95-100% of the cells, as shown 
by staining with antibody 8.9.12.1. TPA further upregu lated th e 
amount ofHLA I on the cells by 10 -20% (Figs 4 and 5). In contrast 
to high HLA class I expression, melanocytes were either HLA-DR 
negative (four of eight cultures) or HLA-DR positivity was limited 
to 2-5% of the me1anocytes (four of eight cultures) and no up-
regulation was observed in TPA-treated cultures. To exclude pre-
sence of CD I-positive cells, normal human me1anocytes cultures 
maintained in either TPA-free or TPA-containing media were 
stained w ith monoclonal antibody BL6 and were found to be nega-
tive. 
Reversibility of TP A Effects on Melanocyte Antigen Ex-
ression To assess the reversibility ofTPA-induced phenotype al-
terations on normal human melanocytes, first- or second-passage 
melanocyte cultures were incubated for 6 d in TPA-contal llln.g 
CMM (50 ng/ml) and after three washes they were further culti-
vated for rwo additiona l weeks in CMM alone. A series of respective 
melanocyte subcultures were maintained in CMM for the same 
period as a contro l. Most of the antigenic changes sti ll persisted In 
the TPA-deprived melanocyte cultures (Fig 7). Surface HMB-45, 
HLA class I, and NGF receptor were still expressed at hi gher levels 
than in untreated controls, whereas ICAM-l remained downregu-
lated in all three melanocyte cultures examined. However, the ef-
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Figure 4: Expression of antigens by nonnal human melanocytes cultured for 6 d in the presence of TPA (50 ng/ml) (speckled bars) in comparison to 
untreated controls (black bars), as found by FACS analysis. Results are given as percent of positive cells. In case of HLA class I numbers show the mean 
value (log) of fluorescence intensity as seven of eight melanocyte cultures (except NHM-5) were 100% positive. The magnitude of the TPA effect on HLA 
class I expression was about the half of that induced by 1000 units/ml interferon-gamma (data not shown). n.d., not done. 
fects of TPA on melanocyte morphology had been completely 
abrogated after 2 weeks cultivation in TP A-free medium. 
Effect ofStaurosporine on the Antigenic Profile of Normal 
Human Melanocytes As TPA acts directly on protein kinase C, 
we investigated the effects of staurosporine, a potent protein kinase 
C inhibitor, alone or in combination with TPA on the antigen 
expression of human melanocytes. For this purpose secondary mela-
nocyte cultures were incubated for 3 d with CMM containing ei-
ther 10 ng/ml staurosporine or 50 ng/ml TPA or their combination 
and determined the antigenic profiles by FACS_ Table I shows that 
staurosporine alone modulated the antigenic phenotype of normal 
human melanocytes similar to TP A by increasing the number of 
A.10_33 and ofNGF receptor-positive cells, enhancing the surface 
expression of HMB-45 and of HLA class I antigens and by decreas-
ing the number of ICAM-l positive cells. Similar effects were ob-
served with the combination of both agents. 
NK- and LAK-Cell Cytotoxicity of Normal Human Melano-
cytes A panel of four different melanocyte cultures maintained 
either in TPA-free or in TPA-containing media was examined for ' 
their susceptibility to killing by allogeneic NK or LAK cells_ Both 
TPA-treated and non-treated melanocytes were not lysed by allo-
geneic NK cells at E/T ratios up to 100: 1. On the contrary, LAK 
cells from several donors lysed allogeneic melanocytes cultured in 
TPA-free medium with rates varying between 10 and 50% at a 64 : 1 
E/T ratio as shown in Table II. Melanocytes exposed to TPA were 
less susceptible to LAK-cell cytotoxicity as could be shown in two of 
four cultures examined with lymphocytes from different donors 
(maximum 40% inhibition of cytotoxiciry at 64: 1 E/T ratio) . This 
inhibition was observed in cultures with lower levels of ICAM-l 
antigen after TPA exposure (NHM-3 and -7), whereas, no signifi-
cant decrease of cytotoxicity was observed in cultures without 
downregulation of ICAM-l (NHM-6 and -8)_ 
DISCUSSION 
The present study demonstrates that the tumor promoter 12-0-te-
tradecanoylphorbol-13-acetate, besides its stimulatory effect on 
melanocyte proliferation, may also accentuate phenotypic charac-
teristics that are frequently associated with melanocyte transforma-
tion_ It induced a neuron-like morphology and altered the ex-
pression of various melanocytic markers. More important, TPA-ex-
posed melanocytes became refractory to killing by allogeneic LAK 
cells, possibly via alterations of melanocyte adhesion molecules such 
as ICAM-L 
Traditional melanocyte culture media utilize TP A to increas~ 
melanocyte growth rates irl vitro [1 ,16]. To investigate the effects of 
TPA on normal melanocytes in vitro we used a culture medium that 
allows selective and rapid proliferation of normal melanocytes in 
absence ofTPA [19] . All compounds used in this medium, with th~ 
exception of cholera toxin, are nOll-toxic naturally occurring mela-
nocyte mitogens_ By selecting these culture conditions we avoided 
long-lasting effects of TPA occurring after ini tial cultivation in 
TPA-containing media and subsequent transfer to TPA-free media. 
Furthermore, we avoided artefacts by measuring antigen expression 
in cells with decreased viability. Under these conditions, TPA ex-
erted only a moderate stimulatory effect on melanocyte prolifera-
tion in four of seven cultures_ In agreement with other observatioru 
[33], our results show that if melanocytes are cultured in modified 
media containing other stimulators, supplementation with T PA 
does not always result in additional stimulation of growth. How-
ever, the number of subcultures obtained in presence of TPA ~ 
greater than without TPA_ In addition, if melanocytes are main-
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. ed in sub-optimal cu lture media, then the effect ofTPA is more tal~nounced. This has been demonstrated in Fig 3, which clearly 
p~ ws that TPA profoundly stimulated NHM-IO proliferation 
5 ~en these were maintained in RMM, but not in CMM, which 
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~oduce maximal proliferation. In contrast to its effect on normal 
~elanocytes, TPA in.hibits proliferation of melanoma cells ill vitro 
[14,15], suggesting different s l ~nal-transductlon pathways bet~een 
b nign and malignant cells activated by TPA. ConSiderable dtffer-
e ces in expression of protein kinase C genes, the major cellu lar 
en get of tumor-promoting phorbol esters, have been reported be-
:een normal melanocytes and malignant melanoma cells [34,35]. 
Using the FACS technique we observed consistent upregulation 
of NGF receptors on melanocyte surface after exposure to TPA, 
rphologically accompa11led by dendrite outgrowth, as prevIOusly de~cribed by Peacocke et at [17]. In agreement with findings of 
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Figure 7. Antigenic profile of NHM-5 melanocytes after 6 d exposure to 
TPA and further cultivation for 2 weeks in TPA-free CMM in comparison 
to non-exposed controls as shown by FACS analysis. A total of 10' mela-
nocytes per sample were analyzed. The x axis of the histograms shows the 
log of the fluorescence intensity and the y axis the number of cells . 
consistently upregulated after TPA-exposure. HMB-45 has been 
proposed as an activation marker [36] and stains i,1 sitll melanoma 
cells but not resting skin melanocytes. TPA induced or upregulated 
also the expression of the progression markers A.1O.33 and A.1.43 
and reduced the differentiation marker K.l.2 antigen on most mela-
nocyte cultures examined. Among melanocyte cultures from differ-
ent donors, however, a certain heterogeneity was observed in their 
response to TPA; not every melanocyte culture showed altered 
A.1.43 or A.IO.33 expression after TPA treatment. This is possibly 
due to an intrinsic property of melanocytic cells of different origin 
to respond to TP A, as longer incubation of the cultures with TPA 
did not result in increased A.l.43 or A.l 0.33 expression. Taking our 
data together, normal melanocytes may acquire ill vitro upon expo-
sure to TP A a profile of antigens that are preferentially expressed in 
the process of melanocytic transformation. Interestingly, chromo-
some ana lysis of melanocytes from both TPA-treated and control 
untreated cultures revealed a normal diploid karyotype (data not 
shown) . 
TPA augmented melanocyte HLA class I expression and reduced 
the expression of rCAM-l. Enhancement of HLA class r by TPA ill 
vitro has been recently reported for melanoma and endothelial cells 
by other authors [1 5,37] . Our study shows for the first time that 
TPA is able to reduce the expression ofICAM-l on human melano-
cytes. This downregulation could be confirmed in several melano-
cyte cultures examined and appeared consistent through different 
experiments and different subcu ltures of the same cells. In previous 
studies TPA has been shown to increase ICAM-l expression on 
cultured keratinocytes but to decrease its appearance on dermalmi-
crovascular endothelial cells [38,39]. We do not know presently 
which biochemical events induced by TP A influence the melano-
cyte ICAM-1 expression . It is well established that protein kinase C 
is a key enzyme in the signal-transduction mechanism ofTPA [~]. 
Recent reports suggest that TP A has a biphasic effect on pro~e.m 
kinase C; short-term exposure of cel ls to TPA caused a~1 mlt1al 
activation of protein kinase C, but long-term incubation ~Ith TPA 
down modulated protein kinase C by increasing the rate ~f It~ degra-
dation [40]. In our study, staurosporine - a potent protem kmase C 
inhibitor-could not restore the TPA-induced downmodulauon of 
ICAM-l in melanocytes; in fact, staurosporine alone or in co.mbina-
tion with TP A reduced melanocyte ICAM-l expression. ThiS mim-
icry ofTPA-action by staurosporine ill vitro was found for all other 
antigens examined. In the context of the biphas ic effect ofTPA on 
protein kinase C activation status, our findings on long-term TPA-
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Table I. Antigen Expression of Normal Human Melanocytes After Exposure to TP A, Staurosporine, or their Combination· 
HMB-45 A.1.43 A.10.33 ICAM-1 NGF Receptor HLA-I HLA-DR 
CMM 90 (73) 22 7 54 22 100 (137) 0 
+TPA 98 (134) 43 18 24 48 100 (154) 0 
+ Staurosporine 98 (110) 41 18 22 47 100 (153) 0 
+ TP A + staurosporine 99 (148) 41 17 13 58 100 (151) 0 
• Secondary melanocyte cultures maintained in CMM were treated for 3-d with 50 ngjml TP A, 10 ngjml staurosporine, or their combination. Binding of monoclonal 
antibodies was evaluated by FACS analysis. Numbers show the percent of antigen-positive cells and numbers in parenthesis the mean value of fluorescence intensity (log). 
treated melanocytes tempt us to speculate that the downmodulation 
of protein kinase C activity rather than its upregulation by TPA 
accounts for the antigenic alterations, as staurosporine, although in 
a different manner than TP A, may also downregulate the protein 
kinase C activity of the cells. In support of this hypothesis, Brooks et 
al [41} reported significantly higher levels of protein kinase C is 
quiescent than in TPA-stimulated proliferating mouse melanocytes 
and suggested that protein kinase C downregulation, and not its 
transient activation, correlates with melanocyte growth. Further 
experiments are needed to address this hypothesis. Interestingly, 
similarities between TP A and staurosporine action have been re-
ported on the differentiation of mouse keratinocytes [42-44]. The 
immunophenotypic changes induced by TP A were long lasting as 
most of the antigenic changes persisted over 2 weeks after removal 
ofTPA, when melanocyte morphology had already been reversed. 
The persistence of antigenic alterations may also explain the find-
ings ofYohn et al [44}, who described no modulation of ICAM-l 
expression by comparing cultured melanocytes in TPA-free and in 
TPA-containing media after initial establishment of cultures with 
TPA. 
LAK-Cell Cytotoxicity The reduced susceptibility of TPA-
treated melanocytes to allogeneic interleukin-2 - activated killer 
cells may result from their altered surface antigen expression. 
rCAM-I, the ligand of LFA-I and a major lymphocyte adhesion 
molecule, has been found decreased in those melanocyte cultures 
that were relatively refractile to LAK cells. This association tempts 
us to speculate that ICAM-I may be involved in the TPA-induced 
LAK resistance of normal human melanocytes cultured in vitro. 
Association between rCAM-I expression and cell-mediated cytotox-
icity has been reported for melanoma cells where low ICAM-l 
expression correlated with relative resistance to both T- and LAK-
cell cytotoxicity [45,46}. Our experiments do not rule out the possi-
bility that other surface molecules modulated by TPA mediate 
LAK-cell resistance. LAK cells have been associated with MHC-
Table II. Susceptibility of TPA-Exposed and Non-Exposed 
Melanocytes to Allogeneic LAl< Cells III Vitro· 
Experiment 1 Experiment 2 
Culture -TPA +TPA - TPA +TPA 
NHM-3! 45 27' 28 16' 
NHM-6 31 28 50 48 
NHM-7 37 22' 19 11' 
NHM-8 31 35 10 8 
• Melanocytes were cultured for 6 d either in TPA-free orTP A-containing medium 
(50 ngjml) in 96-well microtiter plates. Por cytotoxicity assays cultures were washed 
three times and LA]( cells at various EjT ratios were added to each well. For each 
melanocyte culture two experiments-each done five times-using lymphocytes 
from two different donors have been performed. Cytotoxicity rates were estimated 
using the MUH assay. Mean values and standard deviation were calculated (n = 5). 
Numbers show the percent cytotoxicity at an EjT ratio of 64: 1. Standard deviations 
of the experimental values were less than 10%. 
! In this experiment LA!( cells were given at an EjT ratio of 32:1. 
'p<O.G1. 
unrestricted cytotoxicity and high HLA class I expression on targets 
correlated with their decreased killing by LAK cells [47]. HLA class 
I and class II DR antigens, however, were either uniformly modu-
lated by TPA or not at all expressed in culture. An interfering factor 
in our assays might be that trace amounts of TPA on melanocyte 
membrane influence effector cells, but this would be rather a consist-
ent finding in all experiments. Also, repetition of cytotoxicity ex-
periments 1 day after TPA starvation showed again decreased kill-
ing ofTPA-pretreated melanocytes in comparison to controls (data 
not shown). In addition, Simon et al [48] in a series of analogous 
experiments on TPA-activated keratinocytes estimated the levels of 
TPA in culture after extensive washing to the level of < 5 X 10-~ 
ng/m!. 
rn conclusion then, our results indicate that under the influence 
ofTPA a new phenotype of cultured normal human melanocytes 
may arise, characterized by enhanced proliferation, increased ex-
pression of various progression markers, and loss of differentiation 
markers. The effects ofTPA on melanocyte antigen expression are 
long lasting, thus implying a more permanent nature of the TPA-
induced events. The protein kinase C inhibitor staurosporine mim-
icked the immunomodulatory action ofTPA, suggesting an associa-
tion of the TPA-induced events with downmodulation of protein 
kinase C. Moreover, TP A-exposed melanocytes were less suscepti-
ble to LAK-cell cytotoxicity, an effect that correlated with reduced 
rCAM-l expression induced by TP A. 
We I/Jo"ld like to tiraljk Dr. C. HatlskiJor critical readitlg oJthe ",atll/script a'ld Dr. 
R.-D. Wegtler Jor perjor"'itlg karyotype alwlysis. 
REFERENCES 
1. Eisinger M, Marco 0 : Selective proliferation of normal human melano-
cytes in vitro in the presence of phorbol ester and cholera toxin. PrOC 
Nat! Acad Sci USA 79:2018-2022,1982 
2. Gilchrest BA, Vrabel MA, Flynn E, Szabo G: Selective cultivation of 
human melanocytes from newborn and adult epidermis. J Invest 
DermatoI83:370-376,1984 
3. Heclyn M, Rodeck U, Manciami M-L, Cardillo FM, Lang A, Ross AH 
Jambrosic J, Koprowski H: Expression of melanoma-associated an-
tigens in rapidly dividing human melanocytes in culture. Cancer Res 
4~3057-3061, 1987 
4. 
5. 
Nishizuka Y: The role of protein kinase C in cell signal transduction 
and tumor promotion. Nature 308:693-698,1984 
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, RahmsdorfHJ,Jonat 
H, Herrlich P, Karin M: Phorbol-ester inducible genes contain a 
common cis element recognized by a TPA-modulated trans-acting 
factor. Cell 49:729 -739, 1987 
6. Fiirsteberger G, Marks F: Growth stimulation and tumor promotion in 
skin. J Invest Dermatol 81:157S-161S, 1983 
7. Hecker E, Fusenig NE, Kunz W, Marks F, Thielmann HW (cds.): 
Cocarcinogenesis and Biological Effects of Tumor Promoters, Carci-
nogenesis, A Comprehensive Survey, Vol. 7. Raven Press, New 
York,1982 
8. Yuspa SH, Kulesz-Martin M, Ben T, Hennings H: Transformation of 
epidermal cells in culture. J Invest Dermatol 81 :162S-168S, 1983 
VOL. 100. NO.5 MAY 1993 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
Reiners JJ Jr, Slaga TJ: Effects of tumorpromoters on the rate and 
commitment of terminal differentiation of subpopulations of mur-
ine keratinocytes. Cell 32:247 - 255, 1983 
Weinstein IB, Lee L-S, Fisher PB, Mufson A, Yamasaki H: Action of 
phorbol esters in cel! culture: mimicry of transformation, altered 
differentiation, and effects on cell membranes. J Supramol Structure 
12:195-208,1979 
Rabin MS, Doherty P], Gottesman MM: The tumor promoter phorbol 
12-myristatc 13-acetate induces a program of altered gene expres-
sion similar to that induced by platelet-derived growth factor and 
transforming oncogenes. Proc Natl Acad Sci USA 83:357 - 360, 
1986 
Mufson RA, Fisher PB, Weinstein IB: Effect of phorbol ester tumor 
promoters on the expression of melanogenesis in B-16 melanoma 
cells. Cancer Res 39:3915-3919,1979 
Buberman G, Heckman C, Langenbach R: Stimulation of differen-
tiated functions in human melanoma cells by tumor-promoting 
agents and dimethyl sulfoxide. Cancer Res 39:2618 -2624, 1979 
Ziegler-Heitbrock HWL, Munker R, Johnson ], Petersmann I, 
Schmoeckel C, Riethmuller G: In vitro differentiation of human 
melanoma cells analyzed with monoclonal antibodies. Cancer Res 
45:1344-1350,1985 
Guarini L, Temponi M, Edwalds GM, VitaJR, Fisher PB, Ferrone S: In 
vitro differentiation and antigenic changes in human melanoma cell 
lines. Cancer Immunol Immullother 30:262 - 268, 1989 
Balaban R, Ghosh S, Duray P, Kirkwood ]M, Lerner AB: Human 
melanocytes cultured from nevi and melanomas. J Invest Dermatol 
87:95-101,1986 
Peacocke M, Yaar M, Mansur C, Chao M, Gilchrest BA: Induction of 
nerve growth factor receptors on cultured human melanocytcs. Proc 
Nat! Acad Sci 85:5282 - 5286, 1988 
18. Chao-Hsing KA, Hsin-Su YU: A study of the effects of phorbol 12-
myristate-13-acetate on cell differentiation of pure human melano-
cytes in vitro. Arch Dermatol Res 283:119-124, 1991 
19. Krasagakis K, Garbe C, Kruger S, Orfanos CE: Effects of interferons 
on cultured human melanocytes in vitro: interferon-beta but not 
-alpha or -gamma inhibit proliferation and all interferons modulate 
the cell phenotype. J Invest DermatoI97:364-372, 1991 
20. Pittelkow MR: New techniques for the in vitro culture of human skin 
keratinocytes and perspectives on their use for grafting of patients 
with extensive burns. Mayo Clin Proc 61:771-777,1986 
21. Garbe C, Krasagakis K, Zouboulis ChC, Schroder K, Kruger S, Stadler 
R, Orfanos CE: Antitumor activities of interferon-alpha, -beta, and 
-gamma and their combinations on human melanoma cells in vitro: 
changes of proliferation, melanin synthesis and immunophenotype. 
J Invest DennatoI95:231S-237S, 1990 
22. Zouboulis CC, Garbe C, Krasagakis K, Kruger S, Orfanos CE: A 
fluorometric rapid microassay to identify antiproliferative com-
pounds for human melanoma cells in vitro. Melanoma Res 1 :91-96, 
1991 
23. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA: Monoclonal 
antibodies specific for melanocytic tumors distinguish subpopula-
tions of melanocytes. Am J Pathol 123:195 -203, 1986 
24. Suter L, Bruggen], Brocker EB, Sorg C: A tumor-associated antigen 
expressed in melanoma cells with lower malignant potential. Int J 
Cancer 35:787-791, 1985 
25. Driiggen J, Sorg C: Detection of phenotypic differences on human 
malignant melanoma lines and their variant sublines with mono-
clonal antibodies. Cancer Immunol Immunother 15:200-205, 
1983 
26. Malissen D, Rebai N, Liabeuf A, Mawas C: Human cytotoxic T cell 
structures associated with expression of cytolysis 1. Analysis at the 
clonal level of the cytolysis-inhibiting effect of 7 monoclonal anti-
bodies. Eur J Immunol 12:739-747, 1982 
TJ. Lampson LA, Levy R: The populations of la-like molecules on a 
human B cell line. ] ImmunoI125:293-299, 1980 
28. Rothlein R, Dustin MC, Marlin SD, Springer TA: A human intercel-
lular adhesion molecule (ICAM-l) distinct from LFA-l. J Immunol 
137:1270-1275,1986 
29. Chandler CE, Parsons LM, Hosang M, Shooter EM: A monoclonal 
antibody modulates the interaction of nerve growth factor with 
PC12 cells. J BioI Chem 259:6882-6889, 1984 
30. Yonish-Rouach E, ViakJ, Schmitt D, Cordier G, ThivoletJ, Brochier 
TPA-MODULATION OF HUMAN MELANOCYTES 659 
J: Preparation of monoclonal antihuman thymocyte antibodies; un-
expected markers of epidermal cells. In: Serrou B et at (cds.). Current 
Concepts in Human Immunology and Cancer Immunotherapy. El-
sevier Biomedical Press, 1982, pp 17 - 55 
31. Cordell JL, Falini B, Erber WN, Ghosh A, Zainalabideen A, MacDon-
ald S, Pulford KAF, Stein H, Masony DY: Immunoenzymatic label-
ling of monoclonal antibodies using immune complexes of alkaline 
phosphatase and monoclonal anti-alkaline phosphatase (APAAP-
complexes).J Histochem Cytochem 32:219-229,1984 
32. Kriiger-Krasagakes S, Garbe C, Kossman P, Orfanos CE: A rapid and 
sensitive fluorometric microassay for determining cell mediated cy-
totoxicity to adherent growing cell lines. J Immunol Meth 156:1-
8, 1992 
33. Gilchrest BA, Friedmann PS: A culture system for the study of human 
melanocyte physiology. In: Jimbow K (cd.). Stmcture and Function 
of Melanin, Vol. 4. Fuji-shoin C. Ltd., Japan, 1987, pp 1-13 
34. Becker D, Beebe SJ, Herlyn M: Differential expression of protein 
kinase C and cAMP-dependent protein kinase in normal human 
melanocytes and malignant melanomas. Oncogene 5:1133-1139, 
1990 
35. Yamashini DT, Graham M, Buckmeier ]A, Meyskens FL Jr: The 
differential expression of protein kinasc C genes in normal human 
neonatal melanocytcs and metastatic melanomas. Carcinogenesis 
12:105 - 109,1991 
36. Smoller BR, McNutt NS, Hsu A: HMB-45 recognizes stimulated 
melanocytes.J Cman PathoI16:49-53, 1989 
37. Ritchie AJ, Jol~nson DR, Ewenstein BM, Pober JS: Tumor necrosis 
factor lI~duct1on of endothelial cell surface antigens is independent 
of protem kinase C activation or inactivation. Studies with phorbol 
mynstate acetate and staurosporin. J Immunol 146:3056-3062, 
1991 
38. GriffithsCEM, EsmannJ, Fisher GJ, Voorhees]], NickoloffBJ: Dif-
ferent1al modulation of keratinocyte intercellular adhesion mole-
cule-1 expression by gamma interferon and phorbol ester: evidence 
for mvolvement of protein kinase C signal transduction. Br J Der-
matol 122:333 - 342, 1990 
39. Lee KH, Lawley TJ, Xu Y, Swerlick RA: VCAM-1-, ELAM-1-, and 
ICAM-l-independent adhesion of melanoma cells to cultured 
human dermal microvascular endothelial cells. J Invest Dermatol 
98:79-85,1992 
40. Young S, Pa:ker PJ, Ullrich A, Stabel S: Down-regulation of protein 
kmase C 1S due to an increased rate of degradation. Bioche1n J 
244:775-779,1987 
41. Brooks G, Wilson RE, DooleyTP, GossMW, Hart IR: Protein kinase 
C down-regulation, and not transient activation, correlates with 
melanocyte growth. Cancer Res 51 :3281- 3288, 1991 
42. Sako T, Tauber AI, Jcng A Y, Yuspa SH, Blumberg PM: Contrasting 
act10ns of staurosporine, a protein kinase C inhibitor, on human 
neutropl111s and pnmary mouse epidermal cells. Cancer Res 
48:4646 - 4650, 1988 
43 . Dlu.gosz AA, Yuspa SH: Staurosporine induces protein kinase C ago-
Illst effects and maturation of normal and neoplastic mouse keratino-
cytes in vitro. Cancer Res 51 :4677 - 84, 1991 
44. Yohn JJ, Critelli M, Lyons MB, Norris DA: Modulation of melano-
cyte intercellular adhesion molecule-1 by immune cytokines. J In-
vest DermatoI95:233-237, 1990 
45. Anichini A, Mortarini R, Supino R, Parmiani G: Human melanoma 
cells with high susceptibility to cell-mediated lysis can be identified 
on the basis ofICAM-l phenotype, VLA profile and invasive ability. 
lnt] Cancer 46:508 -515,1990 
46. Braakman E. Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, 
Bolhuis RLH: ICAM-melanoma cells are relatively resistant to 
CD3-mediated cell lysis. Int J Cancer 46:475 - 480, 1990 
47. Herberman RD, HiserodtJ , Vujanovic N , Balch C, LotzovaE, Bolhllis 
R, Golub S, Lanier LL, Phillips ]H, Riccardi C, Ritz], Sanro.ni A, 
Schmidt RE, Uchida A: Lymphokine-activated killer actlVlty. 
Characteristics of their effector cells and their progenitors 111 blood 
and spleen. Immunol Today 8:178-181,1987 
48. SimonJC, Cruz PD ]r, Bergstresser PR, Davis LS, Tigelaar RE: Phor-
bol myristate acetate-activated keratinocytes stimulate proliferation 
of resting peripheral blood mononuclear lymphocytes via a MHC-
independent, but protein kinase C- and intercellular adhesion 
molecule-l- dependent, mechanism. J Immunol 146:476 - 484, 
1991 
